296 related articles for article (PubMed ID: 32117589)
21. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract][Full Text] [Related]
22. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
[TBL] [Abstract][Full Text] [Related]
23. PD-1
Li JP; Wu CY; Chen MY; Liu SX; Yan SM; Kang YF; Sun C; Grandis JR; Zeng MS; Zhong Q
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253636
[TBL] [Abstract][Full Text] [Related]
24. Development of Tools for the Selective Visualization and Quantification of TLS-Immune Cells on Tissue Sections.
Klein C; Devi-Marulkar P; Dieu-Nosjean MC; Germain C
Methods Mol Biol; 2018; 1845():47-69. PubMed ID: 30141007
[TBL] [Abstract][Full Text] [Related]
25. Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
Ahmed A; Halama N
Anticancer Res; 2020 Nov; 40(11):6367-6373. PubMed ID: 33109574
[TBL] [Abstract][Full Text] [Related]
26. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
N J; J T; Sl N; Gt B
Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
[TBL] [Abstract][Full Text] [Related]
27. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
[TBL] [Abstract][Full Text] [Related]
28. 12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer.
Tokunaga R; Nakagawa S; Sakamoto Y; Nakamura K; Naseem M; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H; Lenz HJ
Int J Cancer; 2020 Jul; 147(2):532-541. PubMed ID: 32191346
[TBL] [Abstract][Full Text] [Related]
29. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
30. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
[TBL] [Abstract][Full Text] [Related]
31. Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients.
Cai D; Wang X; Yu H; Bai C; Mao Y; Liang M; Xia X; Liu S; Wang M; Lu X; Du J; Shen X; Guan W
Clin Transl Immunology; 2024; 13(2):e1489. PubMed ID: 38322490
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer.
He M; He Q; Cai X; Liu J; Deng H; Li F; Zhong R; Lu Y; Peng H; Wu X; Chen Z; Lao S; Li C; Li J; He J; Liang W
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072348
[TBL] [Abstract][Full Text] [Related]
33. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
[TBL] [Abstract][Full Text] [Related]
34. B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
Lauss M; Donia M; Svane IM; Jönsson G
Clin Cancer Res; 2022 May; 28(9):1751-1758. PubMed ID: 34965949
[TBL] [Abstract][Full Text] [Related]
35. Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer.
Esparcia-Pinedo L; Romero-Laorden N; Alfranca A
Front Immunol; 2023; 14():1231315. PubMed ID: 37622111
[TBL] [Abstract][Full Text] [Related]
36. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.
Jia W; Zhang T; Yao Q; Li J; Nie Y; Lei X; Mao Z; Wang Y; Shi W; Song W
Front Immunol; 2022; 13():870458. PubMed ID: 35844587
[TBL] [Abstract][Full Text] [Related]
37. Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers.
Vanhersecke L; Bougouin A; Crombé A; Brunet M; Sofeu C; Parrens M; Pierron H; Bonhomme B; Lembege N; Rey C; Velasco V; Soubeyran I; Begueret H; Bessede A; Bellera C; Scoazec JY; Italiano A; Fridman CS; Fridman WH; Le Loarer F
Lab Invest; 2023 May; 103(5):100063. PubMed ID: 36801637
[TBL] [Abstract][Full Text] [Related]
38. T follicular helper cells in cancer, tertiary lymphoid structures, and beyond.
Cui C; Craft J; Joshi NS
Semin Immunol; 2023 Sep; 69():101797. PubMed ID: 37343412
[TBL] [Abstract][Full Text] [Related]
39. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J; Chen J; Wang L
J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
[TBL] [Abstract][Full Text] [Related]
40. Tertiary lymphoid structure and B-cell-related pathways: A potential target in tumor immunotherapy.
Qin M; Jin Y; Pan LY
Oncol Lett; 2021 Dec; 22(6):836. PubMed ID: 34712360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]